Hello! My name is Peter Lawrence and I am pleased to introduce the October issue of the Journal of Vascular Surgery and highlight three outstanding papers that are freely available for the next month.
Systematic review and meta-analysis of 21 standard World Health Organization-specific and COVID-19-specific sources through May 3, 2020.
News items of interest to the vascular surgeon must be received at least 8 weeks before the desired month of publication. Announcements published at no charge include those received from a sponsoring society of this Journal, those courses and conferences sponsored by state, regional, national, or international vascular surgical organizations, and university-sponsored continuing medical education courses. Send applicable events to Andrew O’Brien, Journal Manager, at firstname.lastname@example.org. All other news items selected for publication carry a charge of $60.00 US for each insertion, and the fee must accompany the request to publish.
Chronic limb-threatening ischemia (CLTI) encompasses a range of ischemia, neuropathy, and tissue injury. Multiple treatment modalities are employed, treatment courses can be prolonged, and recrudescence is frequent. In 2014, the Society for Vascular Surgery Threatened Limb Classification System (WIfI) was proposed to improve the clinical staging of CLTI, to assist clinicians with assessment of amputation risk and need for revascularization.1 The system involves grading (0-3) the three most important factors that determine the degree of limb threat, namely, wound, ischemia, and infection.
Communications regarding original articles and editorial management should be addressed to Peter Gloviczki, MD, and Peter F. Lawrence, MD, Editors, Journal of Vascular Surgery, 9400 W. Higgins Road, Suite 315, Rosemont IL 60018; telephone: 312-334-2355; fax: 312-334-2320; e-mail: JVASCSURG@vascularsociety.org. Information for authors appears in the January and July issues, at www.jvascsurg.org, and at jvs.editorialmanager.com. Authors should consult this document before submitting manuscripts to this Journal.
Medical treatment of severe intermittent claudication or critical limb-threatening ischemia causing rest pain frequently achieves only partial relief or is not effective at all.
Left colic artery (LCA) aneurysms are rare clinical entities with an incidental diagnosis of <2% of all arterial aneurysms.1 Diagnosis and treatment are essential, given the significant risk for rupture in up to 25% of patients and resultant mortality between 25% and 70%.1,2 We describe a large LCA aneurysm that was successfully managed with endovascular coiling. The patient consented for publication of this report.
As Paraskevas and colleagues1 alluded to in their thoughtful meta-analysis, transcervical carotid artery stenting using flow reversal is not a new concept, with early reports of this technique appearing >15 years ago. The current update of their meta-analysis notably includes the data of centers using the ENROUTE Transcarotid Neuroprotection System (SilkRoad Medical, Sunnyvale, Calif). The recent advancement by SilkRoad Medical in standardization of intraprocedural technique, dedicated systems (flow reversal equipment, stents on short delivery systems, specialized sheaths), and recovery protocols (antiplatelet regimen, statin therapy, blood pressure parameters) has brought this procedure into the mainstream for vascular surgeons.